Skip to main content
TipRanks
Go Ultimate75% OFF

Nektar Therapeutics (0UNL) Revenue

0 Followers

Nektar Therapeutics Revenue

Nektar Therapeutics had a revenue of 9.39M in the quarter ending Sep 30, 2026, with -7.35%. This bring the company's revenue in the last twelve months to 52.19M, Decreased 4.40%. In the fiscal year ending Dec 31, 2025, Nektar Therapeutics had annual revenue of 55.23M with -43.89% growth.

Revenue (ttm)
52.19M
Revenue Growth
-16.64%
P/S Ratio
23.04
Revenue/Employee
$876,698
Employees
63
Market Cap
$1.27B

Revenue Chart

Nektar Therapeutics Revenue - Annual

0250M500M750M1B1.25B1.5B307.71M1.19B114.62M152.91M101.91M92.06M90.12M98.43M55.23M201720182019202020212022202320242025
Revenue History
Download to Excel
GB:0UNL revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202555.23M-43.20M-43.89%
Dec 31, 202498.43M8.30M9.22%
Dec 31, 202390.12M-1.93M-2.10%
Dec 31, 202292.06M-9.85M-9.67%
Dec 31, 2021101.91M-51.01M-33.36%
Dec 31, 2020152.91M38.30M33.41%
Dec 31, 2019114.62M-1.08B-90.40%
Dec 31, 20181.19B885.61M287.81%
Dec 31, 2017307.71M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
GB:0UNL52.19M
WVE70.92M
TRVI0.00
ORIC0.00
NUVB201.73M
PRAX0.00